Cargando…

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial

BACKGROUND: The World Health Organization recommendation on the use of a single low dose of primaquine (SLD-PQ) to reduce Plasmodium falciparum malaria transmission requires more safety data. METHODS: We conducted an open-label, nonrandomized, dose-adjustment trial of the safety of 3 single doses of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ingrid, Diawara, Halimatou, Mahamar, Almahamoudou, Sanogo, Koualy, Keita, Sekouba, Kone, Daouda, Diarra, Kalifa, Djimde, Moussa, Keita, Mohamed, Brown, Joelle, Roh, Michelle E, Hwang, Jimee, Pett, Helmi, Murphy, Maxwell, Niemi, Mikko, Greenhouse, Bryan, Bousema, Teun, Gosling, Roly, Dicko, Alassane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974787/ https://www.ncbi.nlm.nih.gov/pubmed/29342267 http://dx.doi.org/10.1093/infdis/jiy014

Ejemplares similares

Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
por: Dicko, Alassane, et al.
Publicado: (2018)

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial
por: Stone, William, et al.
Publicado: (2022)

Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022)

Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex Ratio
por: Bradley, John, et al.
Publicado: (2019)

Barriers to routine G6PD testing prior to treatment with primaquine
por: Ley, Benedikt, et al.
Publicado: (2017)

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
por: Stone, Will, et al.
Publicado: (2022)

G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials
por: Sepúlveda, Nuno, et al.
Publicado: (2021)

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
por: Domingo, Gonzalo J, et al.
Publicado: (2013)

Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
por: Oulton, Tate, et al.
Publicado: (2022)

Modelling primaquine-induced haemolysis in G6PD deficiency
por: Watson, James, et al.
Publicado: (2017)

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019)

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
por: Chu, Cindy S., et al.
Publicado: (2018)

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
por: Diawara, Fatou, et al.
Publicado: (2017)

Prevalence of G6PD deficiency and G6PD variants amongst the southern Thai population
por: Nuinoon, Manit, et al.
Publicado: (2022)

Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity
por: Pett, Helmi, et al.
Publicado: (2016)

A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance
por: Stone, Will, et al.
Publicado: (2017)

Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression
por: Kalnoky, Michael, et al.
Publicado: (2018)

Production and differential activity of recombinant human wild-type G6PD and G6PD(Viangchan)
por: Vengidasan, Lelamekala, et al.
Publicado: (2020)

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers
por: Rueangweerayut, Ronnatrai, et al.
Publicado: (2017)

Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger
por: Denoeud-Ndam, Lise, et al.
Publicado: (2016)

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
por: White, Nicholas J, et al.
Publicado: (2012)

Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency
por: Boonyawat, Boonchai, et al.
Publicado: (2021)

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
por: Satyagraha, Ari Winasti, et al.
Publicado: (2021)

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
por: Avalos, Sara, et al.
Publicado: (2018)

Prevalence of G6PD Deficiency in Iran
por: Shahjahani, Mohammad, et al.
Publicado: (2013)

Is Hypoglycemia Caused by G6PD Deficiency?
por: Agarwal, Shubham, et al.
Publicado: (2021)

Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects
por: Bancone, Germana, et al.
Publicado: (2016)

Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests
por: Bancone, Germana, et al.
Publicado: (2015)

Structural analysis of clinically relevant pathogenic G6PD variants reveals the importance of tetramerization for G6PD activity
por: Cunningham, Anna D, et al.
Publicado: (2017)

Molecular characterization of G6PD mutations reveals the high frequency of G6PD Aures in the Lao Theung population
por: Sanephonasa, Amkha, et al.
Publicado: (2021)

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
por: Djigo, Oum Kelthoum Mamadou, et al.
Publicado: (2021)

Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PD(Viangchan) and G6PD(Viangchan) (+) (Mahidol): Decreased stability and catalytic efficiency contribute to the clinical phenotype
por: Boonyuen, Usa, et al.
Publicado: (2016)

The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects
por: Bancone, Germana, et al.
Publicado: (2017)

Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency
por: Kahn, Maria, et al.
Publicado: (2017)

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
por: Howes, Rosalind
Publicado: (2014)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
por: Uthman, Olalekan A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kqf8ad9jlllocgc1ats0h2lhi5